Eddingpharm gets Chinese rights to Immutep's IMP321

Immutep S.A. (Orsay, France) granted Eddingpharm Inc. (Shanghai, China) exclusive rights in China to develop and commercialize ImmuFact IMP321. The natural human T cell immunostimulatory factor derive...